Clinical Trials Logo

Filter by:
NCT ID: NCT02074371 Completed - Clinical trials for Coronary Artery Disease

Postoperative Respiratory Depression After Cardiac Surgery

CABG PRD
Start date: January 2012
Phase: N/A
Study type: Observational

Coronary artery bypass graft surgery (CABG) is associated with postoperative respiratory depression. In this study we aimed at investigating perioperative parameters that could predict the nadir of postoperative respiratory function impairment.

NCT ID: NCT02073721 Completed - Clinical trials for Urinary Incontinence

The Importance of Electrical Stimulation as a Treatment for Urinary Incontinence in Patients Prostatectomy

UI
Start date: August 2013
Phase: N/A
Study type: Interventional

The use of electrical stimulation to reduce urinary incontinence in men undergoing prostatectomy exercises of the pelvic floor muscles (MAPs)

NCT ID: NCT02073253 Completed - Heart Failure Clinical Trials

Noninvasive Ventilation and Thoracic-abdominal Kinematics in Heart Failure Patients

Start date: March 2013
Phase: N/A
Study type: Interventional

Introduction: Noninvasive ventilation (NIV) has been used to minimize such impairment and increasing ventilator reserve in individuals with heart failure. Aim: To analyze thoracoabdominal kinematics (TK) in individuals with HF associated to cardiomegaly after using NIV. Methods: A randomized crossover clinical trial with allocation consisted of two experimental phases: NIV and control, 7 days apart of each other. During NIV phase, 30 minutes of bi-level ventilation was performed. Any type of ventilator support was offered during control phase. Optoeletronic plethismography was performed to asses TK.

NCT ID: NCT02072707 Completed - Clinical trials for Tachycardia, Ventricular

Efficacy and Safety of Epicardial VT Ablation Using Contact Force Irrigated Tip Catheter - Pilot Study

Start date: April 2014
Phase: N/A
Study type: Interventional

The investigators hypothesized that combined endocardial and epicardial VT ablation using contact sensor irrigated catheter is safe and achieves a lower recurrence rate than endocardial only ablation in ischemic and non-ischemic patients, for this the investigators will randomize 20 patients in two groups, one with endocardial only ablation and other with combined endocardial and epicardial ablation.

NCT ID: NCT02072694 Completed - Obesity Clinical Trials

Cerebral Blood Flow Changes in People With Obesity After Glucose Consumption

Start date: January 2012
Phase: N/A
Study type: Interventional

This study evaluates the hypothesis that a meal constituted of only glucose produces differences in the brain blood flow in people with obesity that are not observed in people without obesity. These changes, at least in part, could explain the mechanisms involved in maintenance or development of obesity.

NCT ID: NCT02069704 Completed - Clinical trials for Metastatic Colorectal Cancer (mCRC)

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients

Start date: October 29, 2014
Phase: Phase 1
Study type: Interventional

This is a multicenter, open label, randomized bioequivalence study of BEVZ92 (bevacizumab biosimilar) and Avastin® with 2 parallel arms to compare the pharmacokinetic (PK) profile of BEVZ92 and Avastin® in combination with FOLFOX (any) or FOLFIRI chemotherapy. FOLFOX (any) or FOLFIRI will be chosen as per investigator criteria based on the hospital standard of care.

NCT ID: NCT02068937 Completed - Heart Failure Clinical Trials

Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients

Start date: May 2013
Phase: N/A
Study type: Interventional

One of the challenges in treating patients with heart failure (HF) is achieving clinical stability and reducing the hospital readmission rate. A diuretic dose adjustment algorithm developed in the United States (Diuretic Treatment Algorithm, DTA) and later validated for use in Brazil (as the Algoritmo de Ajuste de Diurético, AAD) has proved feasible and readily applicable, but its effect on clinical outcomes has yet to be assessed. This report aims to describe a randomized clinical trial protocol designed to assess the effectiveness of the AAD and of nonpharmacologic management in improving clinical stability and reducing the readmission rate at 90 days in patients with HF.

NCT ID: NCT02067871 Completed - Knee Osteoarthritis Clinical Trials

Treatment of Knee Osteoarthritis: Neuromuscular Electrical Stimulation and Low-level Laser.

Start date: March 2012
Phase: N/A
Study type: Interventional

- The purpose of this study is to determine the effects of low-level laser therapy in combination with neuromuscular electrical stimulation on neuromuscular (muscular strength and morphology) and functional parameters (pain and functional tests) in elderly with knee osteoarthritis. - The hypothesis is that the association of low-level laser therapy with neuromuscular electrical stimulation could reduce joint pain associated with the inflammation and consequently potentiates the effects of electrical stimulation on the muscular system.

NCT ID: NCT02067715 Completed - Tooth Discoloration Clinical Trials

Effectiveness of Sealed In-office Bleaching Technique: Randomized Controlled Clinical Trial

Start date: February 2014
Phase: N/A
Study type: Interventional

Thus, the aim of this study is to evaluate the sealed bleaching technique on tooth sensitivity and bleaching efficacy. The hypothesis is that the sealed bleaching technique reduce the tooth sensitivity when compared to conventional technique, without alters the bleaching efficacy.

NCT ID: NCT02066961 Completed - Prostate Cancer Clinical Trials

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

ASPIRE-PCa
Start date: December 31, 2013
Phase:
Study type: Observational

The purpose of this study is to describe patterns in disease management and to describe clinical outcomes, as well as to identify factors influencing physician treatment decisions including reason(s) for treatment choices and trigger(s) for treatment changes and to document healthcare resource utilization used to manage treatment-related complications.